Abstract
Our ability to give a patient an accurate risk assessment for GvHD is improving. Likewise, novel approaches to GvHD prevention and treatment are allowing for more intensive regimens for patients at greater risk. The ultimate goal of individualizing therapy based on risk has not yet been achieved, but this goal is in sight.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 51-58 |
| Number of pages | 8 |
| Journal | Current opinion in organ transplantation |
| Volume | 10 |
| Issue number | 1 |
| State | Published - Mar 2005 |
| Externally published | Yes |
Keywords
- Acute graft-versus-host disease
- Chronic graft-versus-host disease
- Stem cell transplantation
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation